Epigenomics Launches Epitrial - A New Site Management
Thursday, 01.06.2006
Berlin, Germany and Seattle, WA, USA - Epigenomics today announced the launch of a new site management service
- Epitrial - specifically designed to support biomarker driven drug development in oncology.
Epitrial specializes in the management of oncology clinical drug trials as well as diagnostic trials capitalizing on Epigenomics’ worldwide network of academic and corporate collaborations.
Epitrial takes a step forward in site management by leveraging Epigenomics’ expertise in tumor sample collection and analysis to enrich a sponsor’s clinical trials with biomarker identification and validation.
Epitrial will be officially launched at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting in Atlanta, GA, USA, June 02-06, 2006 (Booth No. 4563).
For more information please visit www.epitrial.com or send us an email at contact@epitrial.com
WebWireID14739
- Contact Information
- Media Contacts
- Epigenomics
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.